Biocon scales biosimilars, cuts debt; analysts bullish post Q2 results (Soban News)

MOFSL and JM Financial retained their Buy ratings, while Nuvama upgraded Biocon to Buy from Hold after the company posted a net profit of ₹85 crore in Q2FY26​MOFSL and JM Financial retained their Buy ratings, while Nuvama upgraded Biocon to Buy from Hold after the company posted a net profit of ₹85 crore in Q2FY26 ​Latest News [ SOBAN NEWS: International and National ]